Catalog Number UNK JUVEDERM VOLUMA-ADDITIVE |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
|
Patient Problems
Unspecified Infection (1930); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/15/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.The event of throat infection, deemed not device related is considered an unexpected adverse drug experience.
|
|
Event Description
|
Healthcare professional (hcp) reported patient was injected 1ml of juvéderm® voluma¿ xc to the t1's and 1ml of juvéderm® volift¿ into both cheeks.About two months later, patient reported after the a throat infection, a late inflammatory reaction developed in the form of raised papules on the skin surface in each area on the cheeks.There were absolutely no papules after the procedure.The condition regressed with steroids.It relapsed when the steroids were stopped.The patient did not request hyaluronidase.Symptoms are on going.This is the same event and the same patient reported under abbvie complaint (b)(4).This mdr is being submitted for the suspect product, juvéderm¿ voluma¿ xc.
|
|
Event Description
|
Healthcare professional (hcp) reported patient was injected 1ml of juvéderm® voluma¿ xc to the t1's and 1ml of juvéderm® volift¿ into both cheeks.About two months later, patient reported after the a throat infection, a late inflammatory reaction developed in the form of raised papules on the skin surface in each area on the cheeks.There were absolutely no papules after the procedure.The condition regressed with steroids.It relapsed when the steroids were stopped.The patient did not request hyaluronidase.Symptoms are on going.This is the same event and the same patient reported under abbvie complaint (b)(4).This mdr is being submitted for the suspect product, juvéderm¿ voluma¿ xc.
|
|
Manufacturer Narrative
|
Previous emdr submission noted the event deemed as an unexpected adverse drug experience.However, upon further review, the device does not meet reporting requirements aligned with us combination product reporting for medical devices.
|
|
Search Alerts/Recalls
|